The finding confirmed a long-held assumption that the more progressive form of the disease SPMS also involves more cognition problems. Some previous research has confirmed that hypothesis, but other studies have contradicted it, zanaflex recall and side affects. Neurocognitive zanaflex recall and side affects affects between 40 and 65 percent of MS patients.
The impairment occurs regardless of the stage of the disease, how long a person has had it, and the severity of their physical disability. And it worsens over time. Zanaflex recall and side affects also assessed 12 healthy volunteers as controls. Both categories of MS patients showed worse cognition than healthy volunteers a finding that confirmed the results of previous studies. A key finding was that the SPMS patients had cognition problems in all areas they were tested for.
Meanwhile, RRMS patients had impairments in three categories initial verbal word encoding, word consolidation, and delayed recall of verbal information.
Interestingly, researchers found no differences in verbal fluency between RRMS patients and healthy people, suggesting that this function is affected only at later stages of the disease. This was particularly true with verbal encoding and processing new items. In addition, SMPS patients had poorer mental processing speed.
Another difference was that SPMS patients also had significantly worse performance in tests of executive function, which deal with behavior, than RRMS patients.
The two groups showed similar patterns of global cognitive function, zanaflex recall and side affects, the researchers wrote. I wish there were more trials offered for our group and new medicines targeted specifically for SPMS. After I was taken off Betaseron due to my body building up an immunity to it, my neurologist has not tried any new medicine. I have zanaflex recall and side affects been getting any treatment for at least 10 years.
This study is just comparing earlier stage MS patients to later. This usually happens after you have MS for a while. You can count relapses in short trials but it would take years to show an effect on progression. Effective drugs will slow down the inflammatory processes leading to this end. The earlier and more effectively you treat MS, the less damage occurs. As far as treatments for preventing further progression, Cladribine should especially be good since it is able to safely get into the brain and lymphatic system to kill the lymphocytes as well as being very effective at stopping acute attacks through the blood-brain barrier relapses, zanaflex recall and side affects.
Our understanding of MS biology is evolving and improving, zanaflex recall and side affects. It would be nice if our news websites covered newer thinking, or at least present that there are different theories. I loved your writing, but tell us more about Cladribine? Has it been tested on SP M, zanaflex recall and side affects.
Have you studied medicine? Please say more diane. My long-term memory helped spark that witty retort! There are several questions I have about the article. Where are the lesions located? Certainly cognitive allopurinol side affects, especially memory loss, accompanies aging, and I think secondary progressive MS does, too. My neurologist wants me to take a chemo drug Aubagio for my MS.
I wonder if any others have had experiences using this drug. I have always been somewhat optimistic that I will be able to overcome the these suttle changes in my life. Progression has been slow but constant over the years. Clinical depression is often associated with MS.
I hope you are seeking treatment for depression concurrently with your MS. There are effective treatments available which can impact your coping abilities. Hey Brian, I feel the same way you do. I was always optimistic before. Now the constant pain, the debilitating fatigue, the cog fog, the decreasing ability to function combined with aging make it hard to keep my spirits up. I also think at times of how I want to end it.